Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

ANDA Submissions Drop To Start FY2021

Perhaps Forced Down By COVID-19

Jan 22 2021

• By Derrick Gingery

Bottle of generic drugs — FDA ANDA approvals were ahead of their FY 2020 pace in the first quarter of FY 2021 • Source: Shutterstock

Related Content

Woodcock's Prophesy Comes True: US FDA ANDA Approvals Decline From Record Levels

Oct 19 2020

ANDA Lull Begins: OGD Receives Four Applications In July

Aug 25 2014

FDA Guides On Bioequivalence Studies And COVID-19

Jan 18 2021

Generic Industry Consolidating But Still Mysterious

Jun 07 2017

New AAM CEO: Traditional Lobbying On Lowering Health Care Costs Can Mix With COVID-19 Talks

Nov 07 2020

US FDA Generic Approvals Peak In April, But Annual Pace Trends Down

May 22 2020

ANDA Avalanche: How Will FDA Deal With The 600 Received This Month?

Jun 30 2014

US FDA Offers More Advice On Mid-Trial Changes For Pandemic-Impacted Studies

Mar 31 2020

Related Companies

Apotex Inc.

Additional Topics

United States Generic Drugs Drug Review Coronavirus COVID-19 Regulation FDA BioPharmaceutical

More from Generics

More from Products

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window